[Home] [Reports] [Startups]

Methodology

This is a Reference report (explained).

Order Report via our online store

 

Ophthalmology Worldwide 2007:
Products, Technologies, Markets and Opportunities in
Ophthalmology Surgical, Diagnostic, Device and Drug Markets Worldwide, Forecasts 2004 - 2012

· 330 pages   ·  199 Exhibits   · 103 Company Profiles   · November 2006   · Report #G125

Worldwide report on products, trends, competitors and markets for vision disorders.

This report details worldwide the incidence and prevalence by country/region of vision disorders (myopia, hyperopia, presbyopia, glaucoma, cataracts and retinal disease), and details the current and projected market for diagnostic and therapeutic products in the management of these vision disorders, including general vision diagnostics, diagnostics for glaucoma, corneal and retinal disorders, and therapeutic options for these disorders including use of pharmaceuticals, surgery and devices.  The report details current products and technologies in use and the status of development of novel products under development.  The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and historic/forecast 2004-2012 (actual data for 2006/2007); competitor market shares; competitor profiles; and market opportunity.  Separate size, growth and competitor share data are presented for the U.S., individual western European countries (UK, Germany, France, BeNeLux, Italy and Spain), Japan and other key international markets; Asia (India, Korea, Australia, Russia and China), the Americas (Canada, Mexico, Brazil) and Middle East and Africa categories.  The report profiles 103 companies, with detailed product development, current positions and future outlook for major competitors, and brief profiles of smaller or more development stage companies with noteworthy novel or advanced research activities in the market.

The report establishes the market size for key international markets (as indicated above) for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market (shifts in share based on technology) as technologies gain or lose relative market performance over this period.

Table of Contents

 

EXECUTIVE SUMMARY

Ophthalmology Background & Market Segments

Vision Diagnostics

Eye Care Products

Cataract Surgery

Refractive Surgery

Glaucoma

Back of Eye

The Ophthalmology Pharmaceutical Market

The Ophthalmic Device Market

 

Section 1:        About vision care

 

1.1       The Eye Care Specialist: Optometrists & Ophthalmologists

 

1.2       Diagnostic Map for Ocular Conditions

 

1.3       Diseases of the Eye and Vision Conditions

1.3.1          Conditions of the Cornea

1.3.2          Cornea Disease Diagnostics

1.3.2.1       Visual Acuity and General Vision Diagnostics

1.3.3          Glaucoma

1.3.3.1       Glaucoma Diagnostics

1.3.4          Cataracts

1.3.4.1       Cataract Diagnostics

1.3.5          Back of Eye Disorders

1.3.5.1       Retinal Diagnostics

Section 2:        THE MARKET FOR DIAGNOSTIC INSTRUMENTATION

 

2.1       Market Overview:  Diagnostic Devices

2.1.1          Hand-held Instruments

2.1.2          Diagnostic Equipment

Section 3:        THERAPEUTIC OPTIONS

 

3.1       Vision Correction Options

3.1.1          Corrective Lenses

3.1.1.1       Eyeglasses--The Old Standby

3.1.2          Contact Lenses

3.1.3          Orthokeratology

3.1.4          Corneal Ring Segments

3.1.5          Refractive Surgery

3.1.5.1       LASIK

3.1.5.2       Custom LASIK (Wavefront-Guided Laser Surgery)

3.1.5.3       Conductive Keratoplasty (CK)

3.1.5.4       Laser Epithelial Keratomileusis (LASEK)

3.1.5.5       PHAKIC IOLs

3.1.5.6       Photorefractive Keratectomy (PRK)

3.1.5.7       Laser Thermal Keratoplasty (LTK)

3.2       Glaucoma Treatment Approaches

3.2.1          Pharmaceutical therapy

3.2.2          Interventional Therapy

3.3       Cornea Diseases and Treatment Options

3.3.1          Allergies

3.3.2          Conjunctivitis (Pink Eye)

3.3.3          Corneal Infections

3.3.4          Dry Eye

3.3.5          Corneal Dystrophies

3.3.5.1       Fuchs' Dystrophy

3.3.5.2       Keratoconus

3.3.5.3       Corneal Transplants

3.3.5.4       Lattice Dystrophy

3.3.5.5       Map-dot-fingerprint Dystrophy

3.3.6          Ocular Herpes

3.3.7          Herpes Zoster (Shingles)

3.3.8          Pterygium

3.3.9          Stevens-Johnson Syndrome

3.4       Cataract Treatment Options

3.4.1          Cataract Surgery

3.4.1.1       Phacoemulsification

3.4.1.2       Hand-held Instruments

3.4.1.3       Intraocular Lenses (IOLs)

3.5       Back of the Eye Disease and Treatment Options

3.5.1          Macular Degeneration

3.5.1.1       Wet and Dry Forms of Macular Degeneration

3.5.1.2       Retinal Detachment

3.5.2          Treatment of Retinal Detachments

3.5.2.1       Laser Photocoagulation

3.5.2.2       Cryopexy

3.5.2.3       Pneumatic Retinopexy

3.5.2.4       Scleral Buckle

3.5.2.5       Pharmaceutical Treatments for Wet AMD

Section 4:        Incidence/Prevalence of Ophthalmic Disorders

 

4.1       Worldwide Incidence and Prevalence of Vision Disorders

4.1.1          The Americas:  Vision Disorders

4.1.2          The Americas:  Keratoconus

4.1.3          Europe

4.1.3.1       Vision Disorders:  Europe

4.1.3.2       Keratoconus:  Europe

4.1.4          Asia/Pacific

4.1.4.1       Vision Disorders:  Asia/Pacific

4.1.4.2       Keratoconus:  Asia/Pacific

4.1.5          Middle East and Africa

4.1.5.1       Vision Disorders:  Middle East & Africa

4.1.5.2       Keratoconus: Middle East & Africa

4.2       Worldwide Incidence and Prevalence of Glaucoma

4.2.1          The Americas

4.2.2          Europe

4.2.3          Asia/Pacific

4.2.4          Middle East and Africa

4.3       Cataracts

4.3.1          Cataracts:  The Americas

4.3.2          Cataracts:  Europe

4.3.3          Cataracts:  Asia/Pacific

4.3.4          Cataracts:  Middle East & Africa

4.4       Retinal Disease

4.4.1          Retinal Disease:  The Americas

4.4.2          Retinal Disease:  Europe

4.4.3          Retinal Disease:  Asia/Pacific

4.4.4          Retinal Disease:  Middle East & Africa

Section 5:        THE MARKET FOR OPHTHALMOLOGY PRODUCTS

 

5.1       Demand for Products and Services

 

5.2       Global Market for Ophthalmic Products

5.2.1          Refractive Surgery

5.2.1.1       Microkeratomes

5.2.1.2       Flap Cutting Lasers

5.2.1.3       Ablation Lasers

5.2.1.4       Glaucoma

5.2.1.5       Cataract

5.2.1.6       Phacoemusification

5.2.1.7       Hand-held Instruments

5.2.2          Implantable Devices

5.2.2.1       IOLs

5.2.2.2       Back of Eye

5.3       Global Market for Ophthalmic Diagnostic Equipment

5.3.1          Ophthalmic Diagnostic Instrument Market, Americas

5.3.1.1       USA: Ophthalmic Diagnostic Instrument Market

5.3.1.2       USA:  Ophthalmic Diagnostic Instrument Market Share (%) by Company

5.3.1.3       Non-USA Americas:  Ophthalmic Diagnostic Instrument Market

5.3.1.4       Non-USA Americas:  Diagnostic Instrument Market Share (%) by Company

5.3.2          Ophthalmic Diagnostic Instrument Market, Europe

5.3.2.1       UNITED KINGDOM:  Ophthalmic Diagnostic Instrument Market

5.3.2.2       UNITED KINGDOM: Ophthalmic Diagnostic Instrument Market Share (%) by Company

5.3.2.3       GERMANY:  Ophthalmic Diagnostic Instrument Market

5.3.2.4       GERMANY:  Ophthalmic Diagnostic Market Share (%) by Company

5.3.2.5       FRANCE:  Ophthalmic Diagnostic Market Share (%) by Company

5.3.2.6       BENELUX:  Ophthalmic Diagnostic Instrument Market

5.3.2.7       BENELUX:  Ophthalmic Diagnostic Market Share (%) by Company

5.3.2.8       ITALY:  Ophthalmic Diagnostic Instrument Market

5.3.2.9       ITALY:  Ophthalmic Diagnostic Market Share (%) by Company

5.3.2.10     SPAIN:  Ophthalmic Diagnostic Instrument Market

5.3.2.11     SPAIN:  Diagnostic Market Share (%) by Company

5.3.2.12     EUROPE:  Ophthalmic Diagnostic Instrument Market

5.3.3          Ophthalmic Diagnostic Instrument Market, Asia-Pacific

5.3.3.1       JAPAN:  Ophthalmic Diagnostic Instrument Market

5.3.3.2       JAPAN:  Ophthalmic Diagnostic Market Share (%) by Company

5.3.3.3       Non-Japan ASIA-PACIFIC:  Ophthalmic Diagnostic Instrument Market

5.3.3.4       Non-Japan ASIA-PACIFIC:  Ophthalmic Diagnostic Market Share (%) by Company

5.3.3.5       TOTAL Asia Pacific:  Ophthalmic Diagnostic Instrument Market

5.3.4          Worldwide:  Ophthalmic Diagnostic Instrument Market by Company

5.4       Global Market for Cataract Surgery

5.4.1          Cataract Surgery Market, Americas

5.4.1.1       USA Cataract Surgery Market

5.4.1.2       USA:  Cataract Surgery Market Share (%) by Company

5.4.1.3       Non-USA Americas:  Cataract Surgery Market

5.4.1.4       Non-USA Americas:  Cataract Surgery Market Share (%) by Company

5.4.1.5       AMERICAS:  Total Cataract Surgery Market ($Millions) by Company

5.4.2          Cataract Surgery Market, Europe

5.4.2.1       UNITED KINGDOM:  Cataract Surgery Market

5.4.2.2       UNITED KINGDOM:  Cataract Surgery Market Share (%) by Company

5.4.2.3       GERMANY:  Cataract Surgery Market

5.4.2.4       GERMANY:  Cataract Surgery Market Share (%) by Company

5.4.2.5       FRANCE:  Cataract Surgery Market

5.4.2.6       FRANCE:  Cataract Surgery Market Share (%) by Company

5.4.2.7       BENELUX Cataract Surgery Market

5.4.2.8       BENELUX:  Cataract Surgery Market Share (%) by Company

5.4.2.9       ITALY Cataract Surgery Market

5.4.2.10     ITALY:  Cataract Surgery Market Share (%) by Company

5.4.2.11     SPAIN Cataract Surgery Market

5.4.2.12     SPAIN:  Cataract Surgery Market Share (%) by Company

5.4.2.13     EUROPE, Cataract Surgery Product Revenues By Company

5.4.3          Cataract Surgery Market, Asia-Pacific

5.4.3.1       JAPAN Cataract Surgery Market

5.4.3.2       JAPAN:  Cataract Surgery Market Share (%) by Company

5.4.3.3       Non-Japan ASIA-PACIFIC:  Cataract Surgery Market

5.4.3.4       Non-Japan ASIA-PACIFIC:  Cataract Surgery Market Share (%) by Company

5.4.3.5       TOTAL Asia Pacific:  Cataract Surgery Market Revenues ($Millions US) by Company

5.4.4          Worldwide:  Cataract Surgery Market by Company

5.5       Global Market for Refractive Surgery

5.5.1          Refractive Surgery Market, Americas

5.5.1.1       U.S. Refractive Surgery Market

5.5.1.2       U.S. Refractive Surgery Market Share (%) by Company

5.5.1.3       Non-USA Americas:  Refractive Surgery Market

5.5.1.4       Non-USA Americas:  Refractive Surgery Market Share (%) by Company

5.5.1.5       AMERICAS:  Total Refractive Surgery Revenues by Company

5.5.2          Refractive Surgery Market, Europe

5.5.2.1       UNITED KINGDOM:  Refractive Surgery Market

5.5.2.2       UNITED KINGDOM:  Refractive Surgery Market Share (%) by Company

5.5.2.3       GERMANY:  Refractive Surgery Market

5.5.2.4       GERMANY:  Refractive Surgery Market Share (%) by Company

5.5.2.5       FRANCE:  Refractive Surgery Market

5.5.2.6       FRANCE:  Refractive Surgery Market Share (%) by Company

5.5.2.7       BENELUX: Refractive Surgery Market

5.5.2.8       BENELUX: Refractive Surgery Market Share (%) by Company

5.5.2.9       ITALY: Refractive Surgery Market

5.5.2.10     ITALY: Refractive Surgery Market Share (%) by Company

5.5.2.11     SPAIN: Refractive Surgery Market

5.5.2.12     SPAIN: Refractive Surgery Market Share (%) by Company

5.5.2.13     EUROPE: Refractive Surgery Market by Company

5.5.3          Refractive Surgery Market, Asia-Pacific

5.5.3.1       JAPAN: Refractive Surgery Market by Company

5.5.3.2       JAPAN: Refractive Market Share (%) by Company

5.5.3.3       Non-Japan ASIA-PACIFIC: Refractive Surgery Market by Country

5.5.3.4       Non-Japan ASIA-PACIFIC: Refractive Market Share (%) by Company

5.5.3.5       TOTAL Asia Pacific: Refractive Market by Company

5.5.4          Worldwide:  Refractive Surgery Market by Company

5.6       Global Market for Ophthalmic Pharmaceuticals

5.6.1          Ophthalmic Pharmaceuticals Market, Americas

5.6.1.1       U.S. Ophthalmic Pharmaceutical Market

5.6.1.2       U.S. Ophthalmic Pharmaceutical Market Share (%) by Company

5.6.1.3       U.S. Ophthalmic Pharmaceutical Market by Segment

5.6.1.4       Non-USA Americas:  Ophthalmic Pharmaceutical Market

5.6.1.5       Non-USA Americas:  Ophthalmic Pharmaceutical Market Share (%) by Company

5.6.1.6       Non-USA Americas:  Ophthalmic Pharmaceutical Market by Segment

5.6.1.7       AMERICAS:  Ophthalmic Pharmaceutical Market by Segment

5.6.2          Ophthalmic Pharmaceuticals Market, Europe

5.6.2.1       UNITED KINGDOM:  Ophthalmic Pharmaceutical Market

5.6.2.2       UNITED KINGDOM:  Ophthalmic Pharmaceutical Market Share (%) by Company

5.6.2.3       GERMANY: Ophthalmic Pharmaceutical Market

5.6.2.4       GERMANY:  Ophthalmic Pharmaceutical Market Share (%) by Company

5.6.2.5       FRANCE: Ophthalmic Diagnostic Instrument Market

5.6.2.6       FRANCE:  Ophthalmic Pharmaceutical Market

5.6.2.7       FRANCE: Ophthalmic Pharmaceutical Market Share (%) by Company

5.6.2.8       BENELUX:  Ophthalmic Pharmaceutical Market

5.6.2.9       BENELUX: Ophthalmic Pharmaceutical Market Share (%) by Company

5.6.2.10     ITALY:  Ophthalmic Pharmaceutical Market

5.6.2.11     ITALY: Ophthalmic Pharmaceutical Market Share (%) by Company

5.6.2.12     SPAIN:  Ophthalmic Pharmaceutical Market

5.6.2.13     SPAIN: Ophthalmic Pharmaceutical Market Share (%) by Company

5.6.2.14     EUROPE:  Ophthalmic Pharmaceutical Market by Company

5.6.2.15     EUROPE:  Ophthalmic Pharmaceutical Market by Segment

5.6.3          Ophthalmic Pharmaceuticals Market, Asia-Pacific

5.6.3.1       JAPAN:  Ophthalmic Pharmaceutical Market by Company

5.6.3.2       JAPAN: Ophthalmic Pharmaceutical Market Share (%) by Company

5.6.3.3       Non-Japan ASIA-PACIFIC:  Ophthalmic Pharmaceutical Market by Company

5.6.3.4       Non-Japan ASIA-PACIFIC: Ophthalmic Pharmaceutical Market Share (%) by Company

5.6.3.5       TOTAL Asia Pacific:  Ophthalmic Pharmaceutical Market by Company

5.6.3.6       TOTAL Asia Pacific:  Ophthalmic Pharmaceutical Market by Segment

5.6.4          Worldwide:  Ophthalmic Pharmaceutical Market

5.6.4.1       Worldwide:  Ophthalmic Pharmaceutical Market by Company

5.6.4.2       Worldwide:  Ophthalmic Pharmaceutical Market by Segment

Section 6:        Company Profiles

 

6.1       Leading Companies

6.1.1          Advanced Medical Optics

6.1.1.1       Overview

6.1.1.2       Products

6.1.1.3       Pipeline

6.1.1.4       Financials

6.1.2          Alcon Laboratories, Inc.

6.1.2.1       Overview

6.1.3          Allergan

6.1.3.1       Overview

6.1.3.2       Products

6.1.3.3       Pipeline

6.1.3.4       Financials

6.1.4          Bausch & Lomb

6.1.4.1       Overview

6.1.4.2       Products

6.1.4.3       Pipeline

6.1.4.4       Financials

6.1.5          Carl Zeiss Meditech

6.1.5.1       Overview

6.1.5.2       Products

6.1.5.3       Pipeline

6.1.5.4       Financials

6.1.6          IntraLase, Inc.

6.1.6.1       Overview

6.1.6.2       Products

6.1.6.3       Pipeline

6.1.6.4       Financials

6.1.7          STAAR Surgical

6.1.7.1       Overview

6.1.7.2       Products

6.1.7.3       Pipeline

6.1.7.4       Financials

6.1.8          Iridex Corporation

6.1.8.1       Overview

6.1.8.2       Products

6.1.8.3       Pipeline

6.1.8.4       Financials

6.2       Other Companies

6.2.1          Acufocus

6.2.2          Addition Technology, Inc.

6.2.3          Advanced Cell Tech, Inc.

6.2.4          American Optisurgical, Inc. (AOI)

6.2.5          Aquasys, Inc

6.2.6          BD Medical Ophthalmic

6.2.7          Biosyntrx, Inc.

6.2.8          Calhoun Vision

6.2.9          CustomVis

6.2.10        Eagle Vision

6.2.11        Eli Lilly

6.2.12        Endo Optiks, Inc.

6.2.13        Escalon Medical Imaging

6.2.14        EyeKon Medical

6.2.15        Eyemaginations

6.2.16        Eyeonics, Inc.

6.2.17        EyeSys Vision, Inc.

6.2.18        FCI Ophthalmics

6.2.19        Genentech

6.2.20        Geuder AG

6.2.21        Glaukos

6.2.22        Haag-Streit

6.2.23        Heidelberg Engineering, Inc.

6.2.24        Heine

6.2.25        Howard Instruments

6.2.26        Huvitz

6.2.27        IOP, Inc.

6.2.28        IRIDEX

6.2.29        iScience Interventional

6.2.30        ISTA Pharmaceuticals

6.2.31        Keeler Instruments

6.2.32        Kowa Optimed

6.2.33        Lacrimedics

6.2.34        Leica Microsystems

6.2.35        Lenstec Inc

6.2.36        Lumenis

6.2.37        MacuScope

6.2.38        MacuSight, Inc.

6.2.39        Marco

6.2.40        Mastel Precision

6.2.41        Medennium

6.2.42        Micro Medical Devices, Inc

6.2.43        Moeller-Wedel.

6.2.44        MST

6.2.45        Neitz Instruments Co

6.2.46        NeoMedix

6.2.47        NeoVista

6.2.48        New World Medical

6.2.49        Nidek, Inc.

6.2.50        Novadaq Technologies

6.2.51        Novartis Ophthalmics

6.2.52        NovaVision Inc.

6.2.53        OASIS Medical

6.2.54        OccuLogix

6.2.55        OculusGen Biomedical

6.2.56        Odyssey Medical

6.2.57        Omni Lens

6.2.58        Ophtec

6.2.59        Optikon 2000 s.p.a.

6.2.60        Optimedica

6.2.61        Optos, Inc.

6.2.62        Optovue.

6.2.63        Pelion Surgical

6.2.64        Pfizer Ophthalmics

6.2.65        Quest Medical

6.2.66        Refractec

6.2.67        Reichert

6.2.68        Regeneron Pharmaceuticals

6.2.69        Rhein Medical

6.2.70        Santen, Inc.

6.2.71        Scan Optics

6.2.72        Schwind Eye-tech Solutions

6.2.73        ScyFIX

6.2.74        Second Sight

6.2.75        Sirion Holdings, Inc.   (formerly Sirion Therapeutics)

6.2.76        Sonogage

6.2.77        Sonomed.

6.2.78        Stereo Optical Company, Inc.

6.2.79        STAAR Surgical

6.2.80        Surmodics

6.2.81        Synemed

6.2.82        Tekia

6.2.83        Titan Surgical

6.2.84        Tomey

6.2.85        Topcon Medical Systems (TMS)

6.2.86        Tracey Technologies

6.2.87        Trevi Technology

6.2.88        Visiogen, Inc.

6.2.89        Vistakon

6.2.90        Vistakon Pharmaceuticals, LLC

6.2.91        Visual Pathways

6.2.92        WaveLight AG

6.2.93        Welch Allyn

6.2.94        Woodlyn, Inc.

6.2.95        Ziemer Ophthalmic Systems AG.

Appendix:  Company Addresses

APPENDIX A: Worldwide Prevalence of Vision Disorders

APPENDIX B: Worldwide Prevalence of Keratoconus

APPENDIX C: Worldwide Prevalence of Glaucoma

APPENDIX D: Worldwide Prevalence of Cataracts

APPENDIX E: Worldwide Prevalence of Back of Eye Disorders

 

List of Exhibits

Exhibit ES-1:  Total Ophthalmic Products Market by Segment, 2006

Exhibit ES-2:  Ophthalmic Product Revenues (Diagnostics, Surgical, Pharmaceuticals) by Country/Region

 

Exhibit 1-1:  Optometrist Practice by Type

Exhibit 1-2:  Ophthalmologists by Sub-Specialty

Exhibit 1-3:  Practicing Ophthalmologists by Type of Practice/Role

Exhibit 1-4:  Ophthalmologists by Practice Type

Exhibit 1-5:  Cross-Sectional Schematic of the Human Eye

Exhibit 1-6:  Snellen Eye Chart

 

Exhibit 2-1:  Hand-Held Instrument Category Offerings, by Manufacturer

Exhibit 2-2: Diagnostic Equipment Used by the Eye Care Professional and Average Selling Prices

Exhibit 2-3:  Worldwide Diagnostic Instrumentation Revenue, U.S. and Non-U.S., by Segment, 2006

Exhibit 2-4:  Diagnostic Instrumentation Offerings, By Manufacturer

Exhibit 2-5:  Percent of Ophthalmic Diagnostic Equipment Sold to O.D. vs M.D. in US vs International (OUS) Markets

 

Exhibit 3-1:  Manufacturers of Corneal Reshaping Lenses

Exhibit 3-2:  Manufacturers of Implantable Corneal Ring Segment Products for Vision Correction

Exhibit 3-3: LASIK Products and Manufacturers

Exhibit 3-4:  Products Used in Custom Ablation LASIK

Exhibit 3-5:  Phakic IOL Manufacturers and Products

Exhibit 3-6:  Products for Non-LASIK Refractive Surgery Procedures

Exhibit 3-7:  Open-Angle Glaucoma Prevalence Rates by Age and Race

Exhibit 3-8:  Share of U.S. Glaucoma Medication Sales by Type, 2005

Exhibit 3-9:  Glaucoma Pharmaceutical Products

Exhibit 3-10:  Medical Device Products for the Treatment of Glaucoma

Exhibit 3-11:  U.S. Glaucoma Treatment Procedures by Type, 2006

Exhibit 3-12:  Pharmaceutical Allergy Medications

Exhibit 3-13:  Anti-Infective and Anti-Inflammatory Ophthalmic Pharmaceutical Products

Exhibit 3-14:  Products for the Treatment of Dry Eye

Exhibit 3-15:  Ophthalmic Drugs by Type, 2004 & 2008

Exhibit 3-16:  Phacoemulsification Systems for Cataract Surgery, U.S. and Rest of World, 2006

Exhibit 3-17:  Phacoemulsification Equipment and Accessories

Exhibit 3-18:  Conventional Intraocular Lens Manufacturers and Products

Exhibit 3-19:  IOL Accessory Manufacturers and Products

Exhibit 3-20:  Cataract Surgery Procedures, U.S. and Worldwide, 2003-2008

Exhibit 3-21:  Multifocal IOL Manufacturers and Products

Exhibit 3-22:  Phakic IOL Products and Manufacturers

Exhibit 3-23:  Pharmaceuticals to Treat Age-related Macular Degeneration

Exhibit 3-24: Alternatives to Pharmaceutical Developments for the Treatment of Wet AMD

Exhibit 3-25:  Manufacturers of Equipment for the Treatment of Retinal Disorders

 

Exhibit 4-1:  The Americas, Prevalence of Vision Disorders

Exhibit 4-2:  The Americas, Prevalence of Keratoconus

Exhibit 4-3:  Europe, Prevalence of Vision Disorders

Exhibit 4-4:  Europe, Prevalence of Keratoconus, by Country

Exhibit 4-5:  Asia-Pacific, Prevalence of Vision Disorders

Exhibit 4-6:  Asia-Pacific, Prevalence of Keratoconus

Exhibit 4-7:  Middle East & Africa, Prevalence of Vision Disorders

Exhibit 4-8:  Middle East & Africa, Prevalence of Keratoconus

Exhibit 4-9:  U.S., Glaucoma Prevalence by Age

Exhibit 4-10:  The Americas, Prevalence of Diagnosed and Undiagnosed Glaucoma, by Country

Exhibit 4-11:  Europe, Glaucoma Prevalence, by Country

Exhibit 4-12:  Asia-Pacific, Glaucoma Prevalence, by Country

Exhibit 4-13:  Middle East & Africa, Glaucoma Prevalence, by Country

Exhibit 4-14:  The Americas, Cataract Prevalence by Age

Exhibit 4-15:  The Americas, Cataract Prevalence, by Country

Exhibit 4-16:  Europe, Cataract Prevalence, by Country

Exhibit 4-17:  Asia-Pacific, Cataract Prevalence, by Country

Exhibit 4-18:  Middle East & Africa, Cataract Prevalence, by Country

Exhibit 4-19:  The America, Prevalence of Diabetic Retinopathy Among Adults

Exhibit 4-20:  The Americas, Age-Related Macular Degeneration Prevalence by Age and Type

Exhibit 4-21:  Europe, Prevalence of Retinal Disease, by Country

Exhibit 4-22:  Asia-Pacific, Prevalence of Retinal Disease, by Country

Exhibit 4-23:  Middle East & Africa, Prevalence of Retinal Disease, by Country

 

Exhibit 5-1:  Healthcare Expenditure by Country

Exhibit 5-2:  Worldwide Ophthalmic Products Market by Segment, 2006

Exhibit 5-3:  Percentage of Refractive Surgery Procedures by Type, Worldwide, 2004-2010

Exhibit 5-4:  Manufacturers and Product Offerings in Refractive Surgery

Exhibit 5-5:  Shares of Flap-Cutting Procedure Market by Company, 2005 & 2010

Exhibit 5-6:  Ophthalmic Pharmaceutical Revenues, by Type, 2008

Exhibit 5-7:  U.S. Glaucoma Procdures by Type, 2005

Exhibit 5-8:  Phacoemulsification Systems for Cataract Surgery, U.S. and ROW, 2005

Exhibit 5-9:  Worldwide Cataract Surgery Market by Product Segment: IOLs, Phaco Equipment and Viscoelastics, 2003-2008

Exhibit 5-10:  USA:  Diagnostic Instrument Market, 2004-2012

Exhibit 5-11:  U.S. Diagnostic Instrument Market Share by Company, 2004-2012

Exhibit 5-12:  Non-USA Americas, Diagnostic Instrument Market, 2004-2012

Exhibit 5-13:  Non-USA Americas:  Diagnostic Instrument Market Share by Company

Exhibit 5-14:  United Kingdom, Diagnostic Instrument Market, 2004-2012

Exhibit 5-15:  United Kingdom, Ophthalmic Diagnostic Instrument Market Share by Company, 2004-2012

Exhibit 5-16:  Germany, Diagnostic Instrument Market, 2004-2012

Exhibit 5-17:  Germany, Diagnostic Market Share by Company, 2004-2012

Exhibit 5-18:  France, Ophthalmic Diagnostic Market Share by Company, 2004-2012

Exhibit 5-19:  BeNeLux, Ophthalmic Diagnostic Instrument Market, 2004-2012

Exhibit 5-20:  BeNeLux, Diagnostic Market Share by Company, 2004-2012

Exhibit 5-21:  Italy, Diagnostic Instrument Market, 2004-2012

Exhibit 5-22:  Italy, Diagnostic Market Share by Company, 2004-2012

Exhibit 5-23:  Spain, Diagnostic Instrument Market, 2004-2012

Exhibit 5-24:  Spain, Diagnostic Market Share by Company, 2004-2012

Exhibit 5-25:  Europe, Diagnostic Instrument Market, 2004-2012

Exhibit 5-26:  Japan, Diagnostic Instrument Market, 2004-2012

Exhibit 5-27:  Japan, Diagnostic Market Share (%) by Company, 2004-2012

Exhibit 5-28:  Non-Japan Asia-Pacific, Ophthalmic Diagnostic Instrument Market, 2004-2012

Exhibit 5-29:  Non-Japan Asia-Pacific, Diagnostic Market Share by Company, 2004-2012

Exhibit 5-30:  Total Asia Pacific, Diagnostic Instrument Market ($000s), 2004-2012

Exhibit 5-31:  Worldwide Ophthalmic Diagnostic Instrument Market ($000s) by Company, 2004-2012

Exhibit 5-32:  USA Cataract Surgery Market, 2004-2012

Exhibit 5-33:  U.S. Cataract Surgery Market Share by Company, 2004-2012

Exhibit 5-34:  Non-USA Americas, Cataract Surgery Market, 2004-2012

Exhibit 5-35:  Non-USA Americas:  Cataract Surgery Market Share (%) by Company, 2004-2012

Exhibit 5-36:  Americas, Total Cataract Surgery Market by Company, 2004-2012

Exhibit 5-37: Total Americas Cataract Surgery Market, 2004-2012

Exhibit 5-38:  United Kingdom, Cataract Surgery Market, 2004-2012

Exhibit 5-39:  United Kingdom, Cataract Surgery Market Share by Company, 2004-2012

Exhibit 5-40:  Germany Cataract Surgery Market, 2004-2012

Exhibit 5-41:  Germany, Cataract Surgery Market Share by Company

Exhibit 5-42:  France, Cataract Surgery Market, 2004-2012

Exhibit 5-43:  France, Cataract Surgery Market Share by Company, 2004-2012

Exhibit 5-44:  BeNeLux, Cataract Surgery Market, 2004-2012

Exhibit 5-45:  BeNeLux, Cataract Surgery Market Share by Company, 2004-2012

Exhibit 5-46:  Italy, Cataract Surgery Market, 2004-2012

Exhibit 5-47:  Italy, Cataract Surgery Market Share by Company, 2004-2012

Exhibit 5-48:  Spain, Cataract Surgery Market, 2004-2012

Exhibit 5-49:  Spain, Cataract Surgery Market Share by Company, 2004-2012

Exhibit 5-50:  Europe, Cataract Surgery Product Revenues by Company, 2004-2012

Exhibit 5-51:  European Revenue Trends for Cataract Surgery Companies, 2004-2012

Exhibit 5-52:  Japan, Cataract Surgery Market, 2004-2012

Exhibit 5-53:  Japan, Cataract Surgery Market Share by Company, 2004-2012

Exhibit 5-54:  Non-Japan Asia-Pacific, Cataract Surgery Market, 2004-2012

Exhibit 5-55:  Non-Japan Asia-Pacific, Cataract Surgery Market Share by Company, 2004-2012

Exhibit 5-56:  Total Asia-Pacific, Cataract Surgery Market Revenues by Company, 2004-2012

Exhibit 5-57:  Worldwide Cataract Surgery Market by Company, 2004-2012

Exhibit 5-58:  U.S. Refractive Surgery Market, 2004-2012

Exhibit 5-59:  U.S. Refractive Surgery Market Share (%) by Company, 2004-2012

Exhibit 5-60:  Non-USA Americas, Refractive Surgery Market, 2004-2012

Exhibit 5-61:  Non-USA Americas, Refractive Surgery Market Share by Company, 2004-2012

Exhibit 5-62:  Americas, Total Refractive Surgery Revenues ($000s), by Company, 2004-2012

Exhibit 5-63:  United Kingdom, Refractive Surgery Market, 2004-2012

Exhibit 5-64:  United Kingdom, Refractive Surgery Market Share by Company, 2004-2012

Exhibit 5-65:  Germany, Refractive Surgery Market, 2004-2012

Exhibit 5-66:  Germany, Refractive Surgery Market Share by Company, 2004-2012

Exhibit 5-67:  France, Refractive Surgery Market, 2004-2012

Exhibit 5-68:  France, Refractive Surgery Market Share by Company, 2004-2012

Exhibit 5-69:  BeNeLux, Refractive Surgery Market, 2004-2012

Exhibit 5-70:  BeNeLux, Refractive Surgery Market Share by Company, 2004-2012

Exhibit 5-71:  Italy, Refractive Surgery Market, 2004-2012

Exhibit 5-72:  Italy, Refractive Surgery Market Share by Company, 2004-2012

Exhibit 5-73:  Spain, Refractive Surgery Market, 2004-2012

Exhibit 5-74:  Spain, Refractive Surgery Market Share by Company, 2004-2012

Exhibit 5-75:  Europe, Refractive Surgery Market by Company, 2004-2012

Exhibit 5-76:  Japan, Refractive Surgery Market by Company, 2004-2012

Exhibit 5-77:  Japan, Refractive Market Share by Company, 2004-2012

Exhibit 5-78:  Non-Japan Asia-Pacific, Refractive Surgery Market by Country

Exhibit 5-79:  Non-Japan Asia-Pacific, Refractive Surgery Market by Company

Exhibit 5-80:  Total Asia Pacific Refractive Market by Company, 2004-2012

Exhibit 5-81:  Worldwide Refractive Surgery Market by Company, 2004-2012

Exhibit 5-82:  Leading Suppliers of Dry Eye Products and Annual Dry Eye Product Sales

Exhibit 5-83:  Worldwide Ophthalmic Pharmaceutical Sales by Supplier

Exhibit 5-84:  U.S. Ophthalmic Drug Revenue Shares by Supplier, 2003-2010

Exhibit 5-85:  U.S. Ophthalmic Pharmaceutical Market, 2004-2012

Exhibit 5-86:  U.S. Ophthalmic Pharmaceutical Market Share) by Company, 2004-2012

Exhibit 5-87:  U.S. Ophthalmic Pharmaceutical Market by Segment, 2004-2012

Exhibit 5-88:  Non-USA Americas, Ophthalmic Pharmaceutical Market, 2004-2012

Exhibit 5-89:  Non-USA Americas, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012

Exhibit 5-90:  Non-USA Americas, Ophthalmic Pharmaceutical Market by Segment, 2004-2012

Exhibit 5-91:  Total Americas, Ophthalmic Pharmaceutical Market by Segment, 2004-2012

Exhibit 5-92:  United Kingdom, Ophthalmic Pharmaceutical Market, 2004-2012

Exhibit 5-93:  United Kingdom, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012

Exhibit 5-94:  Germany, Ophthalmic Pharmaceutical Market, 2004-2012

Exhibit 5-95:  Germany, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012

Exhibit 5-96:  France, Diagnostic Instrument Market, 2004-2012

Exhibit 5-97:  France, Ophthalmic Pharmaceutical Market, 2004-2012

Exhibit 5-98:  France, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012

Exhibit 5-99:  BeNeLux, Ophthalmic Pharmaceutical Market, 2004-2012

Exhibit 5-100:  BeNeLux, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012

Exhibit 5-101:  Italy, Ophthalmic Pharmaceutical Market, 2004-2012

Exhibit 5-102:  Italy, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012

Exhibit 5-103:  Spain, Ophthalmic Pharmaceutical Market, 2004-2012

Exhibit 5-104:  Spain, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012

Exhibit 5-105:  Europe, Ophthalmic Pharmaceutical Market by Company, 2004-2012

Exhibit 5-106:  Europe, Ophthalmic Pharmaceutical Market by Segment, 2004-2012

Exhibit 5-107:  Japan, Ophthalmic Pharmaceutical Market, 2004-2012

Exhibit 5-108:  Japan, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012

Exhibit 5-109:  Non-Japan Asia-Pacific, Ophthalmic Pharmaceutical Market, 2004-2012

Exhibit 5-110:  Non-Japan, Asia-Pacific, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012

Exhibit 5-111:  Total Asia-Pacific Ophthalmic Pharmaceutical Market ($000s) by Company, 2004-2012

Exhibit 5-112:  Total Asia-Pacific Ophthalmic Pharmaceutical Market by Segment, 2004-2012

Exhibit 5-113:  Worldwide Ophthalmic Pharmaceutical Market ($millions) by Company, 2004-2012

Exhibit 5-114:  Worldwide Ophthalmic Pharmaceutical Market ($000s) by Segment, 2004-2012

 

Exhibit 6-1:  Recent Acquisitions Contributing to the AMO Product Line

Exhibit 6-2:  AMO Cataract and Refractive Surgical Brands

Exhibit 6-3:  AMO 2005 Revenues by World Region and Product Category ($000s)

Exhibit 6-4:  Projected 2006 AMO Sales by Product Line

Exhibit 6-5:  Alcon Pharmaceutical &  Surgical Products

Exhibit 6-6:  Alcon Product Launches Adding to International Pipeline

Exhibit 6-7: Alcon Revenue (Millions), 2003-2006

Exhibit 6-8:  2005 Alcon Revenues by World Region and Product Category ($000s)

Exhibit 6-9:  Alcon Projected 2006 Sales by Product Line

Exhibit 6-10:  Allergan Pharmaceutical Products by Category

Exhibit 6-11:  Net Sales of Allergan Specialty Pharmaceutical Products, 2003-2005

Exhibit 6-12: Net Allergan Sales by Geographic Region, 2003-2005

Exhibit 6-13:  Bausch & Lomb 2006 Product Mix by Percentage of Revneues

Exhibit 6-14:  B&L Product Brands by Category

Exhibit 6-15:  B&L Sales Estimates for 2005 and 2006 by Geographic Region

Exhibit 6-16:  The new Carl Zeiss Meditec after CZSurgical acquisition

Exhibit 6-17:  Breakdown of Carl Zeiss Meditec’s Business by Revenue and Business Segment

Exhibit 6-18: Carl Zeiss Meditech Consolidated Sales by Region for FY 2005/2006E

Exhibit 6-19:  IntraLase Revenues by Product and Year

Exhibit 6-20:  IntraLase Revenues by Geographic Region, 2003-2006

Exhibit 6-21:  STAAR Surgical Sales, 2003-2006

Exhibit 6-22:  STAAR Revenues by Product Category, 2006

Exhibit 6-23:  IRIDEX Ophthalmology Revenues by Geography, 2003-2006

Exhibit 6-24:  Growth of IRIDEX International Market Sales, 2003-2006

 

 


This is a Reference report (explained).

 

Products, Technologies, Markets and Opportunities in Ophthalmology Worldwide, 2007

Price:  $950 for print or PDF; add $200 for both. Site/Global License also available.

 

Get this report now by ordering online.

 

Methodology.
MedMarket Diligence Reports are produced through primary and secondary research. Data is gathered from published sources on products and technologies on the market and under development.  Clinicians and industry representatives are interviewed for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data is used to corroborate and support assessments and projections.  Reports are written and researched by industry insiders, whose familiarity with the companies, industry dynamics and other marketplace specifics facilitate the research process and ensure high quality and thorough reports.

 

 

 

Contact: Patrick Driscoll, (949) 891-1753.  (patrick AT mediligence DOT com)

Copyright © 2008 MedMarket Diligence, LLC. All rights reserved.
Revised: 02/16/11

 

 

Or call
+1.949.891.1753
+1.949.627.8099

About Us

 

Read
advanced medical technologies
blog


Medtech Startups

 

MedMarket Diligence Reports

 

Medtech Startups
Online database of recent medtech startups

 

 

Contact Us